Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production News

FDA approves first-ever cancer biosimilar and digital app, but implements another immunotherapy trial hold, this time on Roche. Checl out this week's...
Venclexta/Venclyxto (venetoclax) successfully met its primary endpoint in Phase 3 trials, providing prolonged, progression-free survival in chronic...
Janssen has announced that its psoriasis drug guselkumab has been awarded a positive opinion by the EMA’s Committee for Medicinal Products for...
Roche's Tecentriq has been added to the list of immunotherapy treatments placed on a partial hold by the FDA over safety concerns.
Teva announced last week that it had reached an agreement to sell Paragard, an intrauterine copper contraceptive, to CooperSurgical for $1.1 billion...
The swine flu pandemic that swept the world in 2009 may have had unforeseen consequences in some populations, after researchers discovered a link to...
New CEO for Teva, massive global staff cuts for Lilly, and 'pharma bro' Martin Shkreli finally heads to jail - check out the week's ten most popular...
Johnson and Johnson has announced that it is to back out of a $1.1 billion deal with Achillion Pharmaceuticals to develop the firm’s hepatitis C...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches